LYVTECRO
LIVE

Serial Number

79279646

Owner

Otsuka Pharmaceutical Co., Ltd.

Filing Date

Dec 12, 2019

Add to watchlist:

No watchlists yet
View on USPTO

LYVTECRO Trademark

Serial Number: 79279646 • Registration: 6213623

LYVTECRO is a trademark filed by Otsuka Pharmaceutical Co., Ltd. on December 12, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Otsuka Pharmaceutical Co., Ltd. (566 trademarks)

Chiyoda-ku, Tokyo , JP

Entity Type: 03

TAKARA BIO INC. (51 trademarks)

SETA 3-4-1
OTSU CITY SHIGA , JP

Entity Type: 03

Trademark Details

Filing Date

December 12, 2019

Registration Date

December 8, 2020

Published for Opposition

September 22, 2020

Goods & Services

Medical services; provision of medical information; medical services relating to the removal, treatment and processing of human blood, human cells and stem cells; stem cell therapy services; medical treatment services; medical treatment services with cell preparations; medical treatment services with processed and cultivated cells; human tissue and cell bank services; analysis of human tissues and cells for medical treatment; collection, testing and preservation of human blood, human cells and stem cells

Pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for medical purposes for the prevention and treatment of cancer; regenerative preparations for medical purposes, namely, regenerative cell therapy preparations for the prevention and treatment of cancer; cell preparations, namely, human cells for medical purposes for the treatment of diseases and disorders; stem cells for medical purposes; cells for medical use

Custom processing of human cells for medical purposes for others; custom processing of therapeutic cells for medical purposes for others; custom cultivation of human cells as medical materials for others; custom cultivation of human cells for others for medical purposes; custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals

Scientific and medical research and development; scientific research services relating to the isolation and cultivation of human tissues and cells; analysis of human tissues and cells for medical research; cultivation of human cells for medical research; cultivation of cells for transplant taken from patients

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 8, 2025 REM3
CHANGE OF OWNER RECEIVED FROM IB
Apr 27, 2024 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Mar 12, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 4, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 15, 2021 FICS
FINAL DISPOSITION PROCESSED
Mar 15, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 8, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 8, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 22, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 22, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 2, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 18, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 17, 2020 TROA
NEW REPRESENTATIVE AT IB RECEIVED
May 8, 2020 NREP
REFUSAL PROCESSED BY IB
Apr 24, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 30, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 30, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 13, 2020 RFCR
NON-FINAL ACTION WRITTEN
Mar 12, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 12, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 6, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 2, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 28, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 27, 2020 REPR